Impact of IDH Mutation and Adjuvant Chemo(radio)therapy on Survival Outcome in Grade II/III Astrocytoma
Clinical trial NCT06620926 · COMPLETED
Trial details
- NCT number
- NCT06620926
- Sponsor
- asmaa salama ibrahim
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-01-01
- Primary completion
- 2020-12-30
- Enrollment
- 811
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.